Sign in and upgrade to a paid plan to export price history as CSV.
Sign in and upgrade to a paid plan to export futures history as CSV.
Sign in and upgrade to a paid plan to export price history as CSV.
Sign in and upgrade to a paid plan to export futures history as CSV.

Parnax Lab Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: PARNAXLAB BSE: 506128
₹111.73
▼ -1.64 (-1.45%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
68/100
Moderate
Valuation
64/100
Fairly Valued
Momentum
41/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹128 Cr
PE (TTM)
85.3
Industry median 36.1 (152 companies)
Price to Book
1.3
PEG (TTM)
0.5
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹-9 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
270.00%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
13.59%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
35.57%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
259.57%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
30.34%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
0.95
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.78
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
44.47
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
32.94%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
33.09%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
16.69%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
5.58%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
2.88%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
5.86%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

0 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (0.78)
  • No Return on equity is 15% or more (5.9%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

1 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (9.4% pledged)

Peer comparison

2 of 2 met
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

0 of 4 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.4%
Low 109.9900 · High 117.7400
1W return
-13.2%
Low 105.0000 · High 125.2200
1M return
-15.4%
Low 104.0000 · High 149.5000
52W return
Data unavailable.
Low 104.0000 · High 149.5000
Lifetime High ₹140.7800 (Sept. 1, 2026)
Lifetime Low ₹111.7300 (Sept. 30, 2026)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish3
5D
115.6
10D
119.1
20D
122.2

Delivery and volume

Day avg. delivery
90.5%
Week avg. delivery
79.7%
Month avg. delivery
82.9%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

113.15
Pivot
First resistance116.32
Second resistance120.90
Third resistance124.07
First support108.57
Second support105.40
Third support100.82
Day RSI40.7
Day MFI49.3
Day MACD—
Day MACD signal—

Beta

1M0.96
3M1.74
1Y1.74
3Y1.74

Price change analysis

↓ -15.4%
Over 1 Month
LowHigh
104.00149.50
—
Over 3 Months
LowHigh
104.00149.50
—
Over 6 Months
LowHigh
104.00149.50
—
Over 1 Year
LowHigh
104.00149.50
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹3 Cr
Net profit (June 30, 2026)
₹1 Cr
Basic EPS (June 30, 2026)
₹0.7400

Ranks #134 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter72.30%

Largest holders

NameCategoryShares %Shares
Binoy Baiju ShahPromoter11.9200%1369600
Ila B ShahPromoter11.8600%1361872
Baiju Mahasukhlal ShahPromoter11.5700%1329261
Prakash Mahasukhlal ShahPromoter10.4600%1201676
Mihir Prakash ShahPromoter9.9400%1141250

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 72.30% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
18 May 2018 NAVRATANMAL BADOLA (HUF) Bulk Sell 53,695 55.2700 BSE
24 Apr 2018 DHEERAJ KUMAR LOHIA Bulk Buy 53,737 58.8100 BSE
5 Jun 2017 BHAVIN Y MEHTA Bulk Buy 47,315 52.2500 BSE
5 Jun 2017 BHAVIN Y MEHTA Bulk Sell 47,315 53.6200 BSE
19 Apr 2017 SETU SECURITIES PVT LTD Bulk Buy 2,513 74.3000 BSE
19 Apr 2017 SETU SECURITIES PVT LTD Bulk Sell 78,000 74.1400 BSE
18 Apr 2017 SETU SECURITIES PVT LTD Bulk Buy 88,166 70.8000 BSE
17 Apr 2017 NIKHIL VORA Bulk Buy 50,000 64.9500 BSE
13 Apr 2017 SETU SECURITIES PVT LTD Bulk Buy 48,246 63.8800 BSE
30 Mar 2017 PORINJUV VELIYATH Bulk Buy 100,000 55.5200 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from KRISHNA DEEP TRADE & INVESTMENTS LTD. to Parnax Lab Limited

All corporate actions →

Corporate Announcements

All 4 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 AGM/EGM Parnax Lab Ltd - 506128 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
29 Sep 2026 AGM/EGM Parnax Lab Ltd - 506128 - Shareholder Meeting / Postal Ballot-Outcome of AGM
29 Sep 2026 Company Update Parnax Lab Ltd - 506128 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
28 Sep 2026 Insider Trading / SAST Parnax Lab Ltd - 506128 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (32.9%)
  • Comfortable interest coverage (44.5x)
  • Strong revenue growth YoY (30.3%)

Weaknesses

  • Low Return on Equity (5.9%)
  • Tight liquidity (Current Ratio 0.95)

Opportunities

  • PEG below 1 (0.54) -- earnings growth outpacing its own valuation

Threats

  • PE above 35 (85.3) -- priced for continued strong execution

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Parnax Lab Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.